Skip to content

Effect of Low Dose Dexmedetomidine in Reducing Muscle Pain After Electroconvulsive Therapy

Assessment of Effectiveness of inj. Dexmedetomidine (0.25mcg/kg) vs placebo to reduce succinylcholine induced myalgia in patients undergoing Electroconvulsive therapy: A randomized double blind controlled study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102748
Enrollment
60
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F315- Bipolar disorder, current episodedepressed, severe, with psychotic features Health Condition 2: F333- Major depressive disorder, recurrent, severe with psychotic symptoms Health Condition 3: F428- Other obsessive-compulsive disorder Health Condition 4: F208- Other schizophrenia

Interventions

Intervention1: Inj. Dexmedetomidine: Intravenous 10 min before ECT Control Intervention1: INJ. Normal Saline: Intravenous 10 min before ECT

Sponsors

Sir T Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 2-3 undergoing ECT

Exclusion criteria

Exclusion criteria: Patients who dose not give written inform consent. Uncooperative patients. Patients with 2nd or 3rd degree heart block or persistant bradycardia. Patients on drugs such as beta blocker or antiarrhythmic drugs. Patients with history of allergic to study drugs. Pregnant or nursing mother.

Design outcomes

Primary

MeasureTime frame
Incidence of succinylcholine induced myalgia after ECT assessed using a 4 point myalgia grading scale (0= none, 1= mild, 2= moderate, 3= sever)Timepoint: After ECT 10min, 15min, 30min, 1hr, 2hr, 4hr, 6hr, 8hr

Secondary

MeasureTime frame
1. Severity of succinylcholine induced myalgia 2. Hemodynamic parameter(Heart rate, mean arterial pressure, Spo2%) 3. requirement of rescue analgesia 4. Adverse effectsTimepoint: After ECT 10min, 15min, 30min, 1hr, 2hr, 4hr, 6hr, 8hr

Countries

India

Contacts

Public ContactDr Pratik Khandhar

GMC Bhavnagar

drshilpadoshi@yahoo.in9428810763

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026